The TriClip device may be safe and effective for lowering tricuspid regurgitation by 1 grade or more.
Atrial fibrillation, left ventricular ejection fraction (LVEF), abnormal right ventricular function, and ventricular hypertrophy were found to be associated with a greater risk for aortic valve replacement (AVR), death, or hospitalization for heart failure in patients with moderate aortic stenosis, according to a study published in The American Journal of Cardiology. In this retrospective single-center study,…
Investigators examined whether pretreatment low-density lipoprotein cholesterol levels and aortic stenosis severity affect lipid-lowering therapy to decrease aortic valve replacement.
Fluoroquinolone antibiotic exposure was linked to an increased risk of developing left-sided valvular regurgitation.
Blood pressure lowering might be a useful strategy for prevention of major valvular heart disease.
Investigators sought to determine whether lipoprotein(a) and oxidized phospholipids on apolipoprotein B-100 levels can affect disease activity, disease progression, and clinical events in patients with aortic stenosis.
Early aortic valve replacement (AVR) may improve survival in patients with severe, asymptomatic aortic stenosis.
The severity of lung disease in preterm infants with bronchopulmonary dysplasia and pulmonary hypertension undergoing cardiac catheterization did not correlate with mortality.
Data show 47 percent reduction in risk for rehospitalization for HF symptoms with device implantation
Lipoprotein(a) levels should be measured in mild to moderate calcific aortic valve stenosis to improve patient risk stratification.